Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors

Efficacy And Safety ◽

Term Efficacy ◽

FRI0214 Long-term efficacy and safety of sirukumab in patients with active rheumatoid arthritis despite anti-tumor necrosis factor therapy: results of the randomized, phase 3 sirround-t study

10.1136/annrheumdis-2017-eular.6486 ◽

2017 ◽

Author(s):

Y Tanaka ◽

D Aletaha ◽

P Agarwal ◽

R Kurrasch ◽

PP Tak ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Efficacy And Safety ◽

Phase 3 ◽

Term Efficacy ◽

Factor Therapy ◽

Long-Term Efficacy of Tumor Necrosis Factor Inhibitors for the Treatment of Methotrexate-Naïve Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis

Advances in Therapy ◽

10.1007/s12325-018-0869-8 ◽

2019 ◽

Vol 36 (3) ◽

pp. 721-745

Author(s):

László Gulácsi ◽

Zsombor Zrubka ◽

Valentin Brodszky ◽

Fanni Rencz ◽

Rieke Alten ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Literature Review ◽

Systematic Literature Review ◽

Tumor Necrosis ◽

Meta Analysis ◽

Term Efficacy ◽

Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled tri

International Journal of Rheumatic Diseases ◽

10.1111/1756-185x.12822 ◽

2015 ◽

Vol 19 (11) ◽

pp. 1103-1111 ◽

Cited By ~ 15

Author(s):

Young Ho Lee ◽

Sang-Cheol Bae

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Meta Analysis ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled ◽

Tofacitinib Versus Biologic Treatments in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results From a Network Meta-analysis

Clinical Therapeutics ◽

10.1016/j.clinthera.2016.11.004 ◽

2016 ◽

Vol 38 (12) ◽

pp. 2628-2641.e5 ◽

Cited By ~ 16

Author(s):

Maria-Cecilia Vieira ◽

Samuel H. Zwillich ◽

Jeroen P. Jansen ◽

Brielan Smiechowski ◽

Dean Spurden ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Meta Analysis ◽

Inadequate Response ◽

The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database

Rheumatology International ◽

10.1007/s00296-014-3045-8 ◽

2014 ◽

Vol 34 (12) ◽

pp. 1729-1736 ◽

Cited By ~ 8

Author(s):

Ryoko Sakai ◽

◽

Soo-Kyung Cho ◽

Toshihiro Nanki ◽

Ryuji Koike ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Serious Infection ◽

Necrosis Factor ◽

Over Time

Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry

Arthritis Research & Therapy ◽

10.1186/s13075-015-0583-8 ◽

2015 ◽

Vol 17 (1) ◽

Cited By ~ 33

Author(s):

Ryoko Sakai ◽

◽

Soo-Kyung Cho ◽

Toshihiro Nanki ◽

Kaori Watanabe ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Comparative efficacy and safety of tumor necrosis factor inhibitors and their biosimilars in patients with rheumatoid arthritis having an insufficient response to methotrexate

Zeitschrift für Rheumatologie ◽

10.1007/s00393-021-01041-z ◽

2021 ◽

Author(s):

Young Ho Lee ◽

Gwan Gyu Song

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Insufficient Response ◽

Sarilumab and Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis and Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors

Arthritis & Rheumatology ◽

10.1002/art.39944 ◽

2017 ◽

Vol 69 (2) ◽

pp. 277-290 ◽

Cited By ~ 71

Author(s):

Roy Fleischmann ◽

Janet van Adelsberg ◽

Yong Lin ◽

Geraldo da Rocha Castelar-Pinheiro ◽

Jan Brzezicki ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Inadequate Response ◽

Disease Modifying Antirheumatic Drugs ◽

Antirheumatic Drugs ◽

Disease Modifying ◽

Periodontal Therapy Reduces the Severity of Active Rheumatoid Arthritis in Patients Treated With or Without Tumor Necrosis Factor Inhibitors

Journal of Periodontology ◽

10.1902/jop.2009.080447 ◽

2009 ◽

Vol 80 (4) ◽

pp. 535-540 ◽

Cited By ~ 190

Author(s):

P. Ortiz ◽

N.F. Bissada ◽

L. Palomo ◽

Y.W. Han ◽

M.S. Al-Zahrani ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Periodontal Therapy ◽

Cost-Effectiveness of Sarilumab Added to Methotrexate in the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors

Journal of Managed Care & Specialty Pharmacy ◽

10.18553/jmcp.2019.25.11.1268 ◽

2019 ◽

Vol 25 (11) ◽

pp. 1268-1280

Author(s):

Noemi Muszbek ◽

Clare Proudfoot ◽

Marie Fournier ◽

Chieh-I Chen ◽

Andreas Kuznik ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cost Effectiveness ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Adult Patients ◽

Inadequate Response ◽